Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Lung Cancer

  Free Subscription

Articles published in Am J Pathol

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    November 2021
  1. KHADIRNAIKAR S, Chatterjee A, Shukla S
    Identification and Characterization of Senescence Phenotype in Lung Adenocarcinoma with High Drug Sensitivity.
    Am J Pathol. 2021;191:1966-1973.
    PubMed     Abstract available

    September 2021
  2. WANG Y, Yan F, Nasar A, Chen ZS, et al
    CUL4(high) Lung Adenocarcinomas Are Dependent on the CUL4-p21 Ubiquitin Signaling for Proliferation and Survival.
    Am J Pathol. 2021;191:1638-1650.
    PubMed     Abstract available

    July 2021
  3. GOERTZEN N, Pappesch R, Fassunke J, Bruning T, et al
    Quantum Cascade Laser-Based Infrared Imaging as a Label-Free and Automated Approach to Determine Mutations in Lung Adenocarcinoma.
    Am J Pathol. 2021;191:1269-1280.
    PubMed     Abstract available

    October 2020
  4. YANG Z, Zhang C, Che N, Feng Y, et al
    SET domain-containing 5 (SETD5) facilitates tumor growth and pulmonary metastasis through up-regulation of AKT1 signaling in breast cancer.
    Am J Pathol. 2020 Oct 28. pii: S0002-9440(20)30486.
    PubMed     Abstract available

    June 2020
  5. PEI YF, He Y, Hu LZ, Zhou B, et al
    The Crosstalk between lncRNA-SNHG7/miRNA-181/cbx7 Modulates Malignant Character in Lung Adenocarcinoma.
    Am J Pathol. 2020;190:1343-1354.
    PubMed     Abstract available

    November 2019
  6. MA T, Hu Y, Guo Y, Yan B, et al
    Tumor-Promoting Activity of Long Noncoding RNA LINC00466 in Lung Adenocarcinoma via miR-144-Regulated HOXA10 Axis.
    Am J Pathol. 2019;189:2154-2170.
    PubMed     Abstract available

    September 2019
  7. QIN H, Lu S, Thangaraju M, Cowell JK, et al
    Wasf3 deficiency reveals involvement in metastasis in a mouse model of breast cancer.
    Am J Pathol. 2019 Sep 19. pii: S0002-9440(19)30716.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.